CLINICAL_TRIALS
trial_result
· 2019-01-02
Clinical Trial Update: GSK1120212+GSK2141795 for Cervical Cancer [Phase 2]
Summary
Phase 2 trial of GSK1120212 + GSK2141795 for cervical cancer was terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dana-Farber Cancer Institute | Conditions: Cervical Cancer | Phase 2 | Status: TERMINATED | Results posted: 2019-01-02